Fmr LLC Zymeworks Inc. Transaction History

Fmr LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$4.82 - $7.7 $2.64 Million - $4.21 Million	-547,078 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$6.0 - $16.98 $17.7 Million - $50 Million	-2,944,469 Reduced 84.33%	547,078 $3.58 Million
Q4 2021 Feb 14, 2022	BUY	$15.19 - $29.33 $191,667 - $370,085	12,618 Added 0.36%	3,491,547 $57.2 Million
Q3 2021 Nov 15, 2021	BUY	$27.35 - $37.28 $437,517 - $596,368	15,997 Added 0.46%	3,478,929 $101 Million
Q2 2021 Aug 13, 2021	BUY	$26.5 - $38.23 $91.8 Million - $132 Million	3,462,932 New	3,462,932 $120 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $763M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

Stay updated on Fmr LLC with notifications on news.